Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Deniz Ozdin"'
Publikováno v:
Journal of Pharmacy & Pharmaceutical Sciences, Vol 23 (2020)
Purpose: Over the last 15 years, an ever-increasing proportion of pharmacokinetic bioequivalence studies for European/North American generic submissions appeared to have been conducted in geographical/ethnic populations other than those for which the
Externí odkaz:
https://doaj.org/article/da4404d038fa4f9f959194d42da8c97f
Autor:
Deniz Ozdin, Naveen Sharma, Jorge Lujan-Zilbermann, Philippe Colucci, Isadore Kanfer, Murray P. Ducharme
Publikováno v:
Journal of Pharmacy & Pharmaceutical Sciences, Vol 21, Iss 1 (2018)
Purpose: As per the US FDA guidance issued on June 2, 1995, the establishment of bioequivalence for topical dermatologic corticosteroids is based on comparing the pharmacodynamic (PD) effects of Test and Reference products at the dose duration corres
Externí odkaz:
https://doaj.org/article/ebcc94ded581475cbc5e658269794438
Publikováno v:
Clinical Pharmacology & Therapeutics. 105:350-362
The science of bioequivalence and biosimilarity has greatly evolved over the past 3 decades. Current methods for assessing bioequivalence mostly rely on noncompartmental pharmacokinetic (PK) analyses, which have proven to be reliable and robust for m
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9ba6fe841926991863ddea97d79444d7
https://doi.org/10.1002/cpt.1270
https://doi.org/10.1002/cpt.1270
Publikováno v:
Pharmaceutical Research. 37
The purpose of this study was (a) to suggest a novel dermatopharmacokinetic (DPK) approach from which pharmacokinetic parameters relevant to the bioequivalence (BE) assessment of a topical formulation can be deduced while circumventing the need for n
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e16a47f2962298a1ae02b6a02a0bfd07
https://doi.org/10.1007/s11095-019-2724-2
https://doi.org/10.1007/s11095-019-2724-2
Autor:
Isadore Kanfer, Deniz Ozdin, Philippe Colucci, Jorge Lujan-Zilbermann, Naveen Sharma, Murray P. Ducharme
Publikováno v:
Journal of Pharmacy & Pharmaceutical Sciences, Vol 21, Iss 1 (2018)
Purpose : As per the US FDA guidance issued on June 2, 1995, the establishment of bioequivalence for topical dermatologic corticosteroids is based on comparing the pharmacodynamic (PD) effects of Test and Reference products at the dose duration corre
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9bffd860ba902575bd540a49adfd27ec
https://doi.org/10.18433/jpps30021
https://doi.org/10.18433/jpps30021
Publikováno v:
Expert opinion on drug safety. 13(6)
Serotonergic antidepressants (SAds) are known to increase bleeding events, with a number of recent studies investigating this risk in surgical settings. Our main objective was to synthesize the current evidence to evaluate the clinical importance of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a1a311412bd8820c5defc4de000a62e7
https://pubmed.ncbi.nlm.nih.gov/24717049
https://pubmed.ncbi.nlm.nih.gov/24717049
Publikováno v:
Pharmaceutical Research; Feb2020, Vol. 37 Issue 2, p1-18, 18p, 1 Diagram, 7 Charts, 3 Graphs
Autor:
Arbabi, Mohammad1, Ghodsi, Zahra2, Mahdanian, Abolfazl1 a.mahdanian@hotmail.fr, Noormohammadi, Naser1, Shalileh, Keivan1, Darvish, Fateme1, Ashrafinia, Narges1, Chams, Cheida2
Publikováno v:
Indian Journal of Dermatology. Sep/Oct2011, Vol. 56 Issue 5, p541-545. 5p.